HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 291/4/H1999    most recent 00082.2006v2 00082.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Sacerdoti, D. Articles by Abraham, N. G. Search for Related Content PubMed PubMed Citation Articles by Sacerdoti, D. Articles by Abraham, N. G.

Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase

¹Department of Clinical and Experimental Medicine, Clinica Medica 5, University of Padova, Padova, Italy; and ²Department of Pharmacology, New York Medical College, Valhalla, New York

Submitted 19 January 2006 ; accepted in final form 30 May 2006

11,12-Epoxyeicosatrienoic acid (11,12-EET), a potent vasodilator produced by the endothelium, acts on calcium-activated potassium channels and shares biological activities with the heme oxygenase/carbon monoxide (HO/CO) system. We examined whether activation of HO mediates the dilator action of 11,12-EET, and that of the other EETs, on rat mesenteric arteries. Dose-response curves (10^–9 to 10^–6 M) to 5,6-EET, 8,9-EET, 11,12-EET, 14,15-EET, and ACh (10^–9 to 10^–4 M) were evaluated in preconstricted (10^–6 mol/l phenylephrine) mesenteric arteries (<350 µm diameter) in the presence or absence of 1) the cyclooxygenase inhibitor indomethacin (2.8 µM), 2) the HO inhibitor chromium mesoporphyrin (CrMP) (15 µM), 3) the soluble guanylyl cyclase (GC) inhibitor ODQ (10 µM), and 4) the calcium-activated potassium channel inhibitor iberiotoxin (25 nM). The vasodilator response to 11,12-EET was abolished by CrMP and iberiotoxin, whereas indomethacin and ODQ had no effect. In contrast, the effect of ACh was attenuated by ODQ but not by CrMP. The vasodilator effect of 8,9-EET, like that of 11,12-EET, was greatly attenuated by HO inhibition. In contrast, the mesenteric vasodilator response to 5,6-EET was independent of both HO and GC, whereas that to 14,15-EET demonstrated two components, an HO and a GC, of equal magnitude. Incubation of mesenteric microvessels with 11,12-EET caused a 30% increase in CO release, an effect abolished by inhibition of HO. We conclude that the rat mesenteric vasodilator action of 11,12-EET is mediated via an increase in HO activity and an activation of calcium-activated potassium channels.

epoxygenase; carbon monoxide; endothelial cell; mesenteric artery

This article has been cited by other articles:

				K. Sodhi, K. Inoue, K. H. Gotlinger, M. Canestraro, L. Vanella, D. H. Kim, V. L. Manthati, S. R. Koduru, J. R. Falck, M. L. Schwartzman, et al. Epoxyeicosatrienoic Acid Agonist Rescues the Metabolic Syndrome Phenotype of HO-2-Null Mice J. Pharmacol. Exp. Ther., December 1, 2009; 331(3): 906 - 916. [Abstract] [Full Text] [PDF]

				N. G. Abraham, J. Cao, D. Sacerdoti, X. Li, and G. Drummond Heme oxygenase: the key to renal function regulation Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1137 - F1152. [Abstract] [Full Text] [PDF]

				D. E. Stec, H. A. Drummond, and T. Vera Role of Carbon Monoxide in Blood Pressure Regulation Hypertension, March 1, 2008; 51(3): 597 - 604. [Full Text] [PDF]